The firm, founded in 2019 and based in Los Angeles, seeks to invest in seed, early, and later-stage companies in sectors such as biotechnology, consumer, fintech, deeptech, foodtech, cryptocurrency, healthcare, and technology. Presight takes a global approach to early-stage investment opportunities in software, frontier technologies & biotech, and is backed by Apeiron, the family office of Christian Angermayer, and a group of world-class investors including Moore Capital, Point72, Mike Novogratz, Martin Chavez, Alan Howard, Brent Hoberman, and successful entrepreneurs and investors who contribute their respective network and experience. The firm's flagship fund is investing $600m into the most ambitious founders worldwide from seed to IPO.